Hemo Organic Limited has submitted a regulatory disclosure to BSE Limited intimating the cancellation of a meeting of its Board of Directors. The meeting was previously scheduled to be held on Wednesday, 23rd September, 2026.
The stated reason for the cancellation is "unavoidable reasons." This communication is made in continuation of a prior intimation dated 19th September, 2026, which was submitted under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The letter is signed by Ayush Dharmendrabhai Jasani, Chairman & Additional Director (DIN: 09842741), on behalf of the company.
No financial impact, strategic rationale, or rescheduled date for the board meeting is disclosed in the filing.